help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Silvy, M.
Right arrow Articles by Berthois, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Silvy, M.
Right arrow Articles by Berthois, Y.
Endocrinology Vol. 139, No. 5 2382-2391
Copyright © 1998 by The Endocrine Society


ARTICLES

Differential Dose-Dependent Effects of Epidermal Growth Factor on Gene Expression in A431 Cells: Evidence for a Signal Transduction Pathway That Can Bypass Raf-1 Activation1

Monique Silvy, Pierre-Marie Martin, Naima Chajry and Yolande Berthois

Laboratoire Interactions Cellulaires Intratumorales, CJF INSERM 9311, IFR Jean Roche, Faculté de Médecine Secteur Nord, 13916 Marseille Cedex 20, France

Address all correspondence and requests for reprints to: Dr. Yolande Berthois, Laboratoire Interactions Cellulaires Intratumorales, CJF INSERM 9311, IFR Jean Roche, Faculté de Médecine Secteur Nord, boulevard Pierre Dramard, 13916 Marseille Cedex 20, France. E-mail: berthois.y{at}jean-roche.univ-mrs.fr

Epidermal growth factor (EGF), which plays an important role in normal and tumoral cell growth regulation, displays an ambivalent dose-dependent effect on the proliferation of epithelial cells overexpressing EGF receptor. However, the underlying molecular mechanisms remain obscure. In this study we have examined the regulation of amphiregulin (AR) gene expression by growth inhibitory (10-9 M) and stimulatory (10-12 M) EGF concentrations in A431 cells. The time course of AR messenger RNA (mRNA) accumulation was different with 10-12 and 10-9 M EGF; AR induction by 10-9 M EGF peaked between 1 and 1.5 h, then decreased to the basal level within 2 h. Conversely, the induction by 10-12 M EGF was slightly delayed, but persisted for 4 h. The involvement of tyrosine phosphorylation in AR induction by EGF was suggested by the ability of the tyrosine phosphatase inhibitor sodium orthovanadate to prolong AR expression induced by 10-12 or 10-9 M EGF. In the presence of the protein phosphatase 2A inhibitor, okadaic acid, 10-9 M EGF induced a persistent accumulation of AR mRNA. On the contrary, okadaic acid abrogated the stimulation of AR mRNA level induced by a low EGF concentration, suggesting that both EGF concentrations activated distinct regulatory mechanisms. The signaling components involved in the differential activities of EGF in A431 cells were then examined. We previously reported a relationship between the ambivalent activity of EGF and the p42-mitogen-activated protein (MAP) kinase activity. Thus, 10-12 M EGF induced a sustained MAP kinase activation, whereas 10-9 M EGF led to a sharp, but transitory, activation. The MAP kinases are activated by MAP kinase kinases (MEK1 and MEK2). Whereas no significant effect of 10-12 M EGF could be detected, 10-9 M EGF was shown to activate MEK1 and, to a lesser extent, MEK2. Also, both MAP kinase activation and AR induction by 10-9 M, but not by 10-12 M, EGF were inhibited by the MEK1 inhibitor PD98059. Moreover, the involvement of c-Raf-1 in the signaling pathway induced by EGF was verified. A concentration of 10-9 M EGF induced stimulation of c-Raf-1 kinase activity, whereas 10-12 M EGF not only failed to activate c-Raf-1, but led to a moderate decrease in its kinase activity. These results demonstrate that in EGF receptor-overexpressing cells, EGF may differently affect gene expression and cell proliferation through distinct mechanisms of regulation.




This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. Blanchet, K. Ramgolam, A. Baulig, F. Marano, and A. Baeza-Squiban
Fine Particulate Matter Induces Amphiregulin Secretion by Bronchial Epithelial Cells
Am. J. Respir. Cell Mol. Biol., April 1, 2004; 30(4): 421 - 427.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. J. Anto, M. Venkatraman, and D. Karunagaran
Inhibition of NF-{kappa}B Sensitizes A431 Cells to Epidermal Growth Factor-induced Apoptosis, whereas Its Activation by Ectopic Expression of RelA Confers Resistance
J. Biol. Chem., July 3, 2003; 278(28): 25490 - 25498.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
A. A. Habib, S. J. Chun, B. G. Neel, and T. Vartanian
Increased Expression of Epidermal Growth Factor Receptor Induces Sequestration of Extracellular Signal-Related Kinases and Selective Attenuation of Specific Epidermal Growth Factor-Mediated Signal Transduction Pathways
Mol. Cancer Res., January 1, 2003; 1(3): 219 - 233.
[Abstract] [Full Text]


Home page
Mol. Biol. CellHome page
P. Dent, D. B. Reardon, J. S. Park, G. Bowers, C. Logsdon, K. Valerie, and R. Schmidt-Ullrich
Radiation-induced Release of Transforming Growth Factor alpha Activates the Epidermal Growth Factor Receptor and Mitogen-activated Protein Kinase Pathway in Carcinoma Cells, Leading to Increased Proliferation and Protection from Radiation-induced Cell Death
Mol. Biol. Cell, August 1, 1999; 10(8): 2493 - 2506.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D. J. Webb, D. H. D. Nguyen, M. Sankovic, and S. L. Gonias
The Very Low Density Lipoprotein Receptor Regulates Urokinase Receptor Catabolism and Breast Cancer Cell Motility in Vitro
J. Biol. Chem., March 12, 1999; 274(11): 7412 - 7420.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. R. Xing and R. Kolesnick
Kinase Suppressor of Ras Signals through Thr269 of c-Raf-1
J. Biol. Chem., March 23, 2001; 276(13): 9733 - 9741.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society